Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline for Alcoholic Cigarette Smokers
NCT01169610Phase 3Terminated
- Sponsor
- Mayo Clinic
- Start
- Jan 2011
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of varenicline in alcohol use disorder (AUD), nicotine dependence, sponsored by Mayo Clinic. Started Jan 2011; status: terminated.
02
Drugs
varenicline
03
Conditions
alcohol use disorder (AUD)nicotine dependence
Beyond the preview
Go deeper on NCT01169610.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01169610.